Comparing Semaglutide and Terzipatide: A Review of Patient Satisfaction and Quality of Life Outcomes in Type 2 Diabetes | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 4, Issue 1, April 2024 PDF (740.26 K) | ||
| Document Type: Review Article | ||
| DOI: 10.21608/esdlj.2024.456232 | ||
| Abstract | ||
| Semaglutide and terzipatide are glucagonlike peptide-1 (GLP-1) receptor agonists used for type 2 diabetes management. While both effectively control blood sugar, their impact on patient well-being may differ. This review explores patient satisfaction and quality of life (QoL) associated with semaglutide and terzipatide using patient-reported outcome measures (PROMs). | ||
|
Statistics Article View: 22 PDF Download: 12 |
||
